MOTS-c
Also known as: Mitochondrial ORF of the 12S rRNA type-c
Buy in shop
MOTS-c from $74/kit
5 verified vendors, ≥99% purity, COAs included.
Key Facts: MOTS-c
- Category
- Hormonal
- FDA Status
- Not FDA Approved
- Clinical Status
- Preclinical - Early human studies beginning. FDA Category 2 (pending reclassification to Category 1 per April 15, 2026 HHS announcement; remains Category 2 under current law until formal FDA rule; PCAC review July 23-24, 2026)
- Administration
- Subcutaneous injection
- Typical Dose
- 5-10 mg weekly
- Frequency
- 1-3x weekly
- Duration
- Variable by protocol
Mechanism of Action
MOTS-c works largely through the AMPK pathway, the cell's main energy and fuel-gauge system. The proposed route is that MOTS-c interferes with the folate-AICAR-one-carbon metabolism cycle, which raises AICAR and activates AMPK in skeletal muscle, liver, and fat. Once AMPK is switched on, cells burn more fatty acids, take up more glucose, and ramp up mitochondrial biogenesis. MOTS-c can also move into the cell nucleus under metabolic stress and influence stress-response genes, which is unusual for a mitochondrial peptide and is part of why it is framed as a stress-adaptive signal. Treat the exact pathway details as a working model rather than settled fact, since much of it is still being mapped.
Research Summary
In mice, MOTS-c is genuinely impressive: it improves insulin sensitivity, protects against diet-induced obesity, and older animals given MOTS-c run longer on a treadmill, which is where the exercise-mimetic label comes from. The human story is much thinner. The strongest human finding is observational: exercise raises MOTS-c, with reports of roughly a 12-fold jump in skeletal muscle and about a 1.6-fold rise in circulation after exercise, suggesting it may be one natural messenger behind some exercise benefits. But that is correlation, not proof that injecting MOTS-c reproduces those benefits. As of 2026 there are no completed, published randomized human trials showing that supplemental MOTS-c causes weight loss, better metabolic health, or longer life in people. It is also a known anti-doping target, which tells you it is treated as experimental and performance-relevant, not as an established therapy.
Dosing Information
Note: Animal study doses may not translate directly to humans.
Typical Dosingⓘ
Community experience
5-10 mg weekly
5-15 mg per week
1-3x weekly
Mitochondrial peptide for metabolic health. Take on exercise days. Often used 2-3x weekly.
Research Dosingⓘ
Scientific studies
Doses from research protocols
Doses from Studies
Research doses varied significantly
Duration
Variable by protocol
Administration
Subcutaneous injection
Timing & Administration
Best Time to Take
Morning or pre-workout
3-5 times per week
Food Recommendation
Take on empty stomach
Why This Timing?
MOTS-c enhances metabolic function and exercise capacity. Morning/pre-exercise timing optimizes benefits.
Possible Side Effects
Not everyone experiences these effects. Individual responses vary based on dosage, duration, and personal factors.
- ●Generally well-tolerated
- ●Injection site reactions (persistent bumps)
- ●Palpitations
- ●Nausea and bloating
- ●Fatigue
- ●May trigger histamine release - use caution with MCAS or histamine sensitivity
- ●Potential interactions with metformin
- ●Long-term effects unknown
References
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9905433/
- https://pmc.ncbi.nlm.nih.gov/articles/PMC9854231/
- https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1120533/full
- https://www.usada.org/spirit-of-sport/what-is-mots-c-peptide/
Research This Peptide Further
Buy in shop
MOTS-c from $74/kit
5 verified vendors, ≥99% purity, COAs included.
Frequently Asked Questions
What does MOTS-c do?
MOTS-c is a 16-amino-acid peptide your own mitochondria make, encoded inside the 12S rRNA region of mitochondrial DNA and discovered in 2015. It is studied as a metabolic regulator and a so-called exercise mimetic, because its levels rise when you work out and it improves insulin sensitivity in animals. The catch: the impressive results are almost entirely in mice, with no completed published human efficacy trials.
How does MOTS-c work?
MOTS-c works largely through the AMPK pathway, the cell's main energy and fuel-gauge system. The proposed route is that MOTS-c interferes with the folate-AICAR-one-carbon metabolism cycle, which raises AICAR and activates AMPK in skeletal muscle, liver, and fat. Once AMPK is switched on, cells burn more fatty acids, take up more glucose, and ramp up mitochondrial biogenesis. MOTS-c can also move into the cell nucleus under metabolic stress and influence stress-response genes, which is unusual for a mitochondrial peptide and is part of why it is framed as a stress-adaptive signal. Treat the exact pathway details as a working model rather than settled fact, since much of it is still being mapped.
Is MOTS-c FDA approved?
No, MOTS-c is not currently FDA approved. Current status: Preclinical - Early human studies beginning. FDA Category 2 (pending reclassification to Category 1 per April 15, 2026 HHS announcement; remains Category 2 under current law until formal FDA rule; PCAC review July 23-24, 2026)
What are the side effects of MOTS-c?
Reported side effects include: Generally well-tolerated, Injection site reactions (persistent bumps), Palpitations, Nausea and bloating, Fatigue. Individual responses vary based on dosage, duration, and personal health factors.
What is the typical dose of MOTS-c?
Community-reported common dose: 5-10 mg weekly (1-3x weekly). Range: 5-15 mg per week. Administration: Subcutaneous injection. Community-reported doses. Not medical advice. Consult healthcare provider.
Related Peptides
Peptides commonly compared with MOTS-c or used in similar applications.
Oxytocin
FDAOxytocin is a 9-amino-acid hormone made in the hypothalamus, famous as the chemistry behind labor contractions, breastfeeding, and social bonding. As an injectable drug it is FDA-approved to induce labor and control postpartum bleeding, but the intranasal 'love hormone' versions sold for trust, anxiety, and autism are experimental and the human results are genuinely mixed. The hype runs well ahead of the evidence.
HormonalKisspeptin
Clinical TrialsKisspeptin is the master switch that tells your brain to start reproduction. It is a family of peptides (the full length is kisspeptin-54, with shorter active fragments KP-14, KP-13, and KP-10) made from the KISS1 gene, and it acts as the upstream trigger for the entire reproductive hormone cascade. It is not an approved drug, but it has been tested in real human trials for fertility, hypothalamic amenorrhea, and male hypogonadism, with promising early results.
HormonalGonadorelin
FDAGonadorelin is a synthetic copy of natural GnRH (gonadotropin-releasing hormone), a 10-amino-acid peptide (pGlu-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2) that tells the pituitary to release LH and FSH. It is FDA-approved for evaluating pituitary function and has historical use in inducing ovulation. In the peptide world it is mostly used off-label to keep the testes working during testosterone replacement, and the catch is that timing matters enormously: pulse it and you stimulate, give it continuously and you shut the system down.
HormonalLeuprolide
FDALeuprolide (brand name Lupron) is a synthetic GnRH agonist, a modified peptide about 20 times more potent than natural GnRH, and it is FDA-approved for advanced prostate cancer, endometriosis, uterine fibroids, and central precocious puberty. The clever part is counterintuitive: it works by overstimulating the GnRH system so hard that the pituitary shuts down sex hormone production. It is a real, long-established prescription drug, not a research peptide, and it carries meaningful side effects from the low-hormone state it creates.
HormonalDesmopressin
FDADesmopressin (dDAVP) is a synthetic tweak of the natural hormone vasopressin, redesigned to keep the water-retaining effect while dropping most of the blood-pressure effect. It is a long-established FDA-approved drug used for central diabetes insipidus, bedwetting and nocturia, and certain bleeding disorders like von Willebrand disease and mild hemophilia A. This is settled medicine, not an experimental peptide, and its main real-world danger is straightforward: it can drop your blood sodium dangerously low if you drink too much fluid on it.
HormonalOctreotide
FDAOctreotide is a synthetic eight-amino-acid mimic of the natural hormone somatostatin, the body's main 'off switch' for hormone secretion. It shuts down excess growth hormone, so it is a frontline FDA-approved drug for acromegaly, and it also tames the flushing and diarrhea of hormone-secreting carcinoid and other neuroendocrine tumors. This is real, approved medicine with decades of clinical data behind it, sold as Sandostatin (injectable, since 1988), Sandostatin LAR (monthly depot), and Mycapssa (oral capsule, approved 2020).
HormonalWant updates on MOTS-c research?
Subscribe to get notified when we add new research findings, protocol updates, and related peptide information.